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ABSTRACT
Objective: To evaluate and compare the effectiveness
and tolerability of preoxygenation with the self-inflating
bag-valve-mask (BVM) and non-rebreather mask
(NRM) as are used before emergency anaesthesia.
Design: Device performance evaluation.
Setting: Experimental study.
Participants: 12 male and 12 female healthy
volunteers (age range 24–47) with no history of
clinically significant respiratory disease.
Interventions: End-expiration oxygen measurements
(FEO2) after 3 min of preoxygenation with BVM
(without mechanical assistance) and NRM devices.
Mask pressures were measured and subjective
difficulty of breathing was also assessed with a visual
analogue score (VAS).
Primary and secondary outcome measures: The
final FEO2 achieved was 58.0% (SD 7.3%) for the NRM
compared to 53.1% (SD 13.4%) for the BVM
(p=0.072). Preoxygenation was associated with small
increases in FECO2 that were greater for the BVM
(0.50%; 95% CI 0.48 to 0.52) than the NRM (0.29%;
95% CI 0.31 to 0.28); this difference was statistically
significant (p=0.028). Both devices were well tolerated
on VAS assessment of difficulty of breathing although
this was higher for the BVM than the NRM (median
VAS 1.85/10 compared to 1.1/10; p=0.041). Inspiratory
and expiratory mask pressures were higher for the
BVM.
Conclusions: In healthy volunteers, the NRM
performs comparably to the BVM in terms of the
degree of denitrogenation achieved although neither
performed well. Although it was well tolerated, the
BVM was subjectively more difficult to breathe through
and was associated with greater mask pressures and a
small increase in FECO2 consistent with hypoventilation
or rebreathing. Our results suggest that preoxygenation
with the NRM may be a preferable approach in
spontaneously breathing patients.
Emergency anaesthesia is a high-risk interven-
tion, particularly when undertaken in an envir-
onment outside of the operating theatre or
emergency department such as the prehospi-
tal environment where available resources may
be suboptimal. Preoxygenation before induc-
tion of anaesthesia is an important safety pro-
cedure and aims to replace residual nitrogen
in the lungs with oxygen. The denitrogenation
of the functional residual capacity provides a
reserve oxygen store which may transiently
prevent arterial oxygen desaturation even
during prolonged apnoea1 as might result
ARTICLE SUMMARY
Article focus
▪ Preoxygenation is an important safety procedure
before emergency anaesthesia and aims to prevent
hypoxia in the event of prolonged apnoea.
▪ The self-inflating bag-valve-mask (BVM) is com-
monly used for preoxygenation when an anaes-
thetic circuit is not available, such as in the
prehospital environment.
▪ Recently the use of non-rebreather masks (NRM)
as an alternative has become common to avoid
increased work of breathing but the effectiveness
of this approach has not been formally evaluated.
Key messages
▪ The BVM and NRM are comparable techniques in
terms of the degree of denitrogenation achieved.
▪ The BVM is well tolerated but subjectively more dif-
ficult to breath through than the NRM, which may
lead to reduced patient compliance. Therefore, the
NRM may be a reasonable alternative.
▪ By comparison with the existing literature,
however, neither technique is as effective as the
use of a traditional anaesthetic circuit.
Strengths and limitations of this study
▪ Generalisation of the results from healthy volun-
teers in an optimal environment to critically ill
patients in a suboptimal environment is difficult.
▪ Our results are likely to represent a ‘best case’
upper bound to device performance in combat-
ive, critically ill or obtunded patients where
effective preoxygenation would be expected to be
further compromised.
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in the event of a difﬁcult tracheal intubation.
Preoxygenation is particularly important in circumstances
where securing the airway is predicted to be difﬁcult or
where artiﬁcially ventilating a patient without a properly
secured airway may be dangerous, such as in emergency
anaesthesia and/or in patients at risk of aspiration. The
critically ill may be both particularly prone and sensitive
to rapid arterial oxygen desaturation making optimal pre-
oxygenation before emergency anaesthesia even more
important.
A common procedure utilised clinically involves 3 min
of tidal breathing from a high oxygen concentration
source, that is, through a tightly ﬁtting mask connected
to an anaesthetic circuit that prevents rebreathing of
CO2. The performance of such anaesthetic circuits has
been extensively evaluated. Measurement of end expira-
tory oxygen fraction (FEO2) gives an estimate of the
degree of denitrogenation and therefore the adequacy
of preoxygenation. Optimal preoxygenation increases
the FEO2 to approaching 90%.
2 Other studies have
demonstrated that extending the period of preoxygena-
tion beyond 3 min does not lead to a clinically signiﬁ-
cant improvement in denitrogenation.3 4
In some situations, most notably in the prehospital
environment, anaesthetic breathing circuits are less avail-
able. In the absence of an anaesthetic circuit, the self-
inﬂating bag-valve-mask (BVM) device is often used5 as
it is readily available, can still provide ventilation with air
in the event of oxygen supply failure and can be used
for both preoxygenation or to assist breathing. However,
the BVM may increase resistance to passive breathing
and feel claustrophobic. Gentle assistance with breathing
using light pressure on the BVM can overcome this but,
if not carefully performed, could also cause stomach dis-
tension in semiconscious patients, increasing the risk of
aspiration.
As a possible alternative, a number of investigators
have examined whether effective preoxygenation can be
delivered with a standard oxygen face-mask (‘Hudson’
mask), which is less tightly ﬁtting and therefore well tol-
erated.4 6 7 Results from these studies have shown that
the degree of denitrogenation achieved is inferior with
the Hudson mask. This is due to air entrainment
around the mask during inspiration, which occurs
because peak inspiratory ﬂow may be far greater than
the rate at which oxygen can be practically supplied
from cylinders.
High-ﬂow non-rebreather masks (NRM) are similar to
traditional Hudson masks but additionally incorporate a
simple valve system so that peak inspiratory ﬂow demand
may be met with oxygen from an attached reservoir bag
rather than air entrained through leaks around the
mask. These masks are now commonplace in hospitals
and in the prehospital setting and are almost always ini-
tially applied to patients who are critically ill. In prin-
ciple, the presence of a reservoir bag should improve
the effectiveness of these devices for preoxygenation
and therefore they may offer a safe and potentially
better-tolerated alternative to the BVM. On this basis,
the practise of using an NRM for emergency preoxy-
genation is becoming increasingly widespread. However,
to date, there has not been a study comparing these two
methods and air entrainment may still be signiﬁcant
compared to a cushioned mask.8 In this study, we
compare the efﬁcacy of the BVM and the NRM for pre-
oxygenation and the ease of breathing with each mask
in volunteers.
METHODS
Volunteer group
The study was reviewed and approved by the local
ethical review board (NRES Committee East of
England—Cambridge Central, study 12/EE/0057). A
total of 24 healthy volunteers were recruited from hos-
pital staff by advertisement. The volunteers had a
working association with the investigators but no
organisational involvement in the study. Volunteers
with acute respiratory disease or receiving treatment
for chronic respiratory disease, including asthma, were
excluded. Pregnancy, body mass index of greater than
35, known or suspected coronary or cerebrovascular
disease and previous exposure to bleomycin were also
exclusion criteria. Informed consent was obtained
from all participants.
STUDY DESIGN
The study was conducted with the subjects in the fully
supine position. Each subject was preoxygenated for
3 min by normal tidal breathing with each mask in turn
and the procedure repeated (ie two attempts with each
mask with the results averaged). An oxygen ﬂow rate of
10 l/min was chosen for both the BVM and NRM and
this was sufﬁcient that the reservoir bag remained well
ﬁlled at end inspiration in all cases. Thus, at this ﬂow
rate, free supply of oxygen to meet peak inspiratory ﬂow
without avoidable entrainment should have been avail-
able. FEO2 and FECO2 measurements were made before
and after each mask was tested by slow end expiratory
reserve exhalation into a mouthpiece connected to a
calibrated gas analyser (Datex-Ohmeda S/5, GE
Healthcare, Chalfont St. Giles, Buckinghamshire, UK).
The subjects breathed room air between each set of
observations until the end expired samples had returned
to baseline composition.
The starting mask was predetermined by block ran-
domisation so as to eliminate a systematic error from
‘training’ effects. There are two sizes of BVM commonly
used in our unit. Half the subjects were randomly allo-
cated to a 1.5 litre BVM the other half tested with a
1 litre BVM with pressure relief valve (type 7152 and
7153, respectively, Intersurgical Ltd, Berkshire, UK). An
appropriate anaesthetic mask, chosen by the investiga-
tors, was used (type 1515 or 1516, Intersurgical Ltd,
Berkshire, UK). Subjects were instructed to apply the
BVM tightly onto their face so that there was no leak
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and the investigators monitored this. The NRM (type
1102, Intersurgical Ltd, Berkshire, UK) was securely
ﬁtted by the investigators by adjustment of elastic head-
band and nose clip.
To ascertain the resistance to breathing added by each
of the devices, a pressure transducer was placed inside the
mask. For the BVM, a manometer line connected to a
standard invasive blood pressure transducer (Ref
T445211B, Edwards Lifesciences, Irvine, Califonia, USA)
was positioned under the seal of the mask. The line was
sufﬁciently thin as to not disrupt the seal. For the NRM
the manometer line was attached to a blunt needle
inserted through the mask body adjacent to the nose clip.
Our pressure recording equipment recorded maximum
and minimum mask pressures to the nearest mmHg.
Finally, subjects were asked to subjectively evaluate
each of the masks using a visual analogue scale with zero
representing ‘normal breathing’ and 10 representing
‘almost impossible to breathe’.
The primary outcome measure was the end expiratory
oxygen concentration after breathing through the mask
for 3 min. The secondary outcome measure was the ease
of breathing through each mask as indicated by the pres-
sure measurements and visual analogue scale assess-
ment. Changes in breathing pattern could be partially
assessed from the end expiratory carbon dioxide
(FECO2) results before and after using the mask.
DATA ANALYSIS
Statistical analysis was carried out using R (version
2.15.0). Two-tailed tests were employed throughout.
Student’s t test was used for parameters where there was
no evidence of non-normality (Shapiro-Wilks test).
Otherwise, Wilcoxon signed-rank test was used: p values
were estimated using a 1000 repetition Monte Carlo
‘jitter’ method to allow for ties. A statistical signiﬁcance
of 5% was assumed. Using the literature 2–4 9 to estimate
the likely variability in FEO2. The sample size was chosen
to have at least 80% power to detect a 10% difference in
FEO2 (corresponding approximately to a clinically sig-
niﬁcant increase in oxygen reserve of 1 min) at the 5%
signiﬁcance level.
RESULTS
The subject characteristics are summarised in table 1.
Mean measured FEO2 after preoxygenation with a BVM
and NRM was 53.1% (SD 13.4%) and 58.0% (SD 7.3%),
respectively (ﬁgure 1) (p=0.072, paired t test). The FEO2
achieved after preoxygenation did not differ signiﬁcantly
between large and small BVMs (p=0.58, unpaired t test).
Baseline FECO2 measurements were comparable
between BVM and NRM groups. Preoxygenation was
associated with small increases in FECO2 that were
greater for the BVM (0.50%; 95% CI 0.48 to 0.52) than
the NRM (0.29%; 95% CI 0.31 to 0.28) and this differ-
ence was statistically signiﬁcant (p=0.028).
The maximum recorded positive expiratory pressure
was 1 mmHg for the BVM but unrecordable with our
equipment for the NRM (p=0.016, Wilcoxon signed-rank
test). Maximum negative inspiratory pressure was up
to −3 mmHg for the BVM and −2 mmHg for the NRM
(p<0.001, Wilcoxon signed-rank test).
The median visual analogue scale rated difﬁculty in
breathing was 1.85/10 (range 0–7.2/10) for the BVM
compared to 1.1/10 (range 0–5.9/10) for the NRM
(p=0.041, Wilcoxon signed-rank test).
DISCUSSION
Overall, we have shown that the NRM and BVM were
comparable in terms of the degree of denitrogenation
achieved. While the ﬁnal FEO2 achieved was 4.9%
greater for the NRM than the BVM, this difference was
not statistically signiﬁcant. While the average FEO2
achieved with the BVM was comparable with the NRM,
the spread in the data was greater.
Our values of FEO2 achieved after BVM preoxygena-
tion were somewhat lower than those achieved in
Stafford et al,9 who found the mean FEO2 to be 74.2%.
However, we measured FEO2 at the end of an expiratory
reserve breath rather than sampling end tidal gas from
the mask, and this is likely to be higher due to mixing
Table 1 Subject characteristics
Subject characteristic Range
Age (years) 22–47
Sex 12 male, 12 female
Height (m) 1.6–1.88
Weight (kg) 52–95
Body mass index (kg/m2) 19.10–28.08
Smoking history (N/ex-smoker/Y) 17/6/1
Figure 1 Scatterplot of FEO2 after preoxygenation for the
bag-valve-mask (BVM) and non-rebreather masks (NRM)
devices.
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and incomplete exhalation which may account for the
discrepancy. We believe our method is a more accurate
measure of true end-alveolar oxygen and the actual
degree of oxygen reserve obtained.
There was a statistically signiﬁcant difference between
the maximum and minimum mask pressures generated
with the NRM and BVM (around 1–2 mmHg given the
limited resolution of our monitor). This implies a greater
resistance to breathing with the BVM and, while small, is
not insigniﬁcant compared to the normal pressure
changes seen in eupnoea and could become important
in the case of dyspnoea. That the FECO2 was higher after
preoxygenation could be due to either partial rebreathing
or hypoventilation. However, the increased airway pres-
sures and subjective difﬁculty in breathing shown by the
visual analogue scale data might give credence to the
latter explanation. While the increase in FECO2 may not
be clinically signiﬁcant, any additional resistance to
breathing is clearly undesirable and likely to reduce toler-
ance in anxious, disorientated or combative patients.
While it would appear that in a prehospital or emer-
gency setting, the BVM and NRM are similarly effective,
it is worth pointing out that comparison of our data with
the literature conﬁrms that both underperform an
anaesthetic circuit9 for preoxygenation. It is common
clinical experience that mask-sampled (tidal breathing)
FEO2 levels approach 80 or 90% after 3 min preoxygena-
tion with a Bain or circle system.
Our study has a number of potential limitations. One
potential weakness in the study design is the integrity of
the seal created by the subjects holding the BVM on
themselves. However, it was felt that tightly holding a
mask onto a healthy volunteer was likely to cause dis-
comfort, which may have led them to radically alter
their breathing or even withdraw from the study
altogether. To mitigate this, the participants were clearly
instructed to hold the mask ﬁrmly and avoid leaks and
the investigators visually monitored this. In most cases,
mild blanching of the skin under the mask was visible.
Irrespective of this, it seems unlikely that the seal with a
cushioned mask and therefore the potential for air
entrainment would have been signiﬁcantly worse than
for the NRM design. The BVM has a valve arrangement,
which may allow room air to enter the system if mask
pressures are sufﬁciently negative and while we have not
evaluated the performance of this or the effect of mask
dead-space, and it is conceivable that any of the above
factors may have contributed to the greater variability in
average FEO2 seen with the device. At the same time it is
important to remember that ﬁrm application of an
anaesthetic mask to dyspnoeic or otherwise confused/
obtunded patients typically increases agitation and often
makes maintaining an airtight seal difﬁcult. So, while we
cannot exclude the possibility of small leaks in our vol-
unteer study, it is doubtful if this can ever be the case in
the emergency situation either.
Another limitation of the study is that critically ill
patients are unlikely to have a normal breathing pattern.
They may have reduced or increased minute volume as
well as a reduced or increased respiratory volume.
Therefore, the levels of preoxygenation achieved with
the BVM and NRM may exceed the efﬁcacy in a critically
ill patient: that is, our study is likely to represent a ‘best
case’. Clearly, the BVM offers the potential for ventila-
tory support, which the NRM does not.
In conclusion, there was no signiﬁcant difference
between the efﬁcacy of preoxygenation with a BVM or
an NRM. The NRM was associated with lower mask pres-
sures in normal ventilation and was subjectively better
tolerated. Its use for preoxygenation is simple although
clearly it is imperative to conﬁrm that all equipment,
including a method for ventilation, be immediately avail-
able and functioning before anaesthesia is induced.
Although inferior, the BVM can still be well tolerated
and offers the option of assisting ventilation, which is
also an important consideration in emergency care.
Comparison with previous published results suggests that
both devices are inferior to an anaesthetic circuit and
the use of such a purpose-designed system which is valve-
less and has minimal resistance to ﬂow is therefore to be
encouraged wherever possible. Our results, however,
emphasise the limited safety margin available in emer-
gency anaesthesia.
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